RGM.20.010 – Beta cell replacement therapy for type 1 diabetes
Route: Regenerative medicine: game changer moving to broad areas of application
cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?
Type 1 diabetes is a lifelong autoimmune disease which specifically destroys the insulin producing beta-cells residing in the pancreatic islets […]
View the initiative
RGM.20.012 – Patient-specific beta-cell replacement therapy using pluripotent stem cells for the treatment of diabetes mellitus
Route: Regenerative medicine: game changer moving to broad areas of application
cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?
In the Netherlands more than 100,000 people have severe deficiency of insulin-producing beta-cells, such as in type 1 diabetes (T1D), […]
View the initiative
RGM.20.005 – Rational Engineering of a MODEL for OSsification (reMODELos)
Route: Regenerative medicine: game changer moving to broad areas of application
cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?
Bone tissue gives rise to the bodily structures that provide shape, protect vital organs, and enable movement. Additionally, bone tissue […]
View the initiative
RGM.20.006 – From Bench to Brain (Bench2Brain): combining autologous stem cells with biomaterials for brain repair.
Route: Regenerative medicine: game changer moving to broad areas of application
cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?
Brain injuries caused by a traumatic injury (TBI), stroke or tumor removal, have a significant impact on patient health and […]
View the initiative
RGM.20.007 – Large-scale neo-cartilage engineering, a regenerative treatment for osteoarthritis
Route: Regenerative medicine: game changer moving to broad areas of application
cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?
Osteoarthritis (OA) is a degenerative joint disease affecting over 1.3 million people in the Netherlands, causing an estimated annual economic […]
View the initiative
RGM.20.003 – Bioengineering of donor organs through pre-transplant ex vivo perfusion
Route: Regenerative medicine: game changer moving to broad areas of application
cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?
With an aging population and rising healthcare costs, the need for personalized strategies in medicine has grown considerably. In this […]
View the initiative
RGM.20.004 – DIABULC (Diabetic Ulcera: Novel Integrated Therapy and Monitoring)
Route: Regenerative medicine: game changer moving to broad areas of application
cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?
Approach: patient-motivated/driven multidisciplinary consortium that combine patient demands and input with experimental clinical therapy, state-of-the art antimicrobial peptides, clinical application […]
View the initiative